ARCB is in a bearish Phase 9 of the Adhishthana cycle. The recent bearish trend could persist until 2029. ARCB’s Cakra breakdown indicates strong selling pressure. Short-term bullish rallies are unlikely to last. Investors should remain cautious about potential weakness.
BofA upgraded ARCB from Underperform to Neutral with a target of $74. ARCB is gaining market share, offsetting core yield pressure. 2Q25 EPS estimate increased to $1.60; FY25 to $5.85. ARCB's tons per day rose 5%, outperforming industry trends. Analyst expects strong profit margins through Q3 despite seasonal drops.
ArcBest's Q2 profit missed expectations due to lower revenue per shipment. Net income increased to $46.9 million, but adjusted EPS missed consensus. Revenue fell 2.3% to $1.08 billion, with declines in asset-based and asset-light revenue. Company cites soft rate environment impacting asset-light revenues and margins. Stock gained 1.2% YTD, underperforming compared to S&P 500's 14.2% gain.
- ArcBest Corporation has favorable earnings estimate revisions, indicating potential for an earnings beat. - The Most Accurate Estimate is $1.57 per share, higher than the Zacks Consensus Estimate of $1.54. - Positive Zacks Earnings ESP and Rank #3 suggest potential for a positive surprise in earnings. - Analysts raising estimates right before earnings could indicate favorable trends for ARCB. - Good things are ahead for ArcBest, with potential for a beat in the upcoming report. Price Impact Rating: Bullish Impact Horizon Rating: Short-term Type: Earnings